CD8A and neoplasm: The number of active CD8+ lymphocytes increased in the presence of CM of BMDMΦs treated with KO CAF CM but not of those treated with WT CAF CM (Fig. 7A); accordingly, CD8‐dependent toxicity over tumor cells was also higher, although the results were not significant (Fig. 7B).